lncRNAs as Biomarkers of Hepatocellular Carcinoma Risk and Liver Damage in Advanced Chronic Hepatitis C
<b>Background/Objectives:</b> LncRNAs have emerged as promising biomarkers due to their role in gene regulation of carcinogenesis and presence in biological fluids. Liquid biopsies offer a less invasive alternative to tissue biopsies, improving early cancer diagnosis and surveillance. He...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Current Issues in Molecular Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1467-3045/47/5/348 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850257457107959808 |
|---|---|
| author | Driéle B. dos Santos Geysson J. Fernandez Letícia T. Silva Giovanni F. Silva Estela O. Lima Aline F. Galvani Guilherme L. Pereira Adriana C. Ferrasi |
| author_facet | Driéle B. dos Santos Geysson J. Fernandez Letícia T. Silva Giovanni F. Silva Estela O. Lima Aline F. Galvani Guilherme L. Pereira Adriana C. Ferrasi |
| author_sort | Driéle B. dos Santos |
| collection | DOAJ |
| description | <b>Background/Objectives:</b> LncRNAs have emerged as promising biomarkers due to their role in gene regulation of carcinogenesis and presence in biological fluids. Liquid biopsies offer a less invasive alternative to tissue biopsies, improving early cancer diagnosis and surveillance. Hepatocellular carcinoma (HCC) is among the most lethal and prevalent cancers. Late diagnoses contribute to poor prognosis, particularly in chronic hepatitis C (CHC) patients, which is a major risk factor for HCC. Tissue biopsies for HCC diagnosis pose risks, including tumor dissemination, highlighting the urgent need for noninvasive biomarkers. Several lncRNAs are deregulated in HCC and may be potential markers for assessing HCC risk in CHC. This study evaluated seven lncRNAs as plasma biomarkers for HCC risk in CHC. <b>Methods:</b> lncRNA expression was analyzed by RT-qPCR in three groups: CHC patients who developed HCC within a 5-year follow-up (HCCpos), CHC patients who did not develop HCC within a 5-year follow-up (HCCneg), and healthy blood donors (CG). <b>Results:</b> This study found that plasma lncRNAs HULC and RP11-731F5.2 are potential biomarkers for HCC risk, while RP11-731F5.2 and KCNQ1OT1 may serve as noninvasive biomarkers for liver damage due to HCV infection. <b>Conclusions:</b> These findings highlight the potential of lncRNAs in enhancing early diagnosis and monitoring of HCC in CHC patients. |
| format | Article |
| id | doaj-art-a6b775cd3a1845d5955b287bbefd28ac |
| institution | OA Journals |
| issn | 1467-3037 1467-3045 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Current Issues in Molecular Biology |
| spelling | doaj-art-a6b775cd3a1845d5955b287bbefd28ac2025-08-20T01:56:25ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452025-05-0147534810.3390/cimb47050348lncRNAs as Biomarkers of Hepatocellular Carcinoma Risk and Liver Damage in Advanced Chronic Hepatitis CDriéle B. dos Santos0Geysson J. Fernandez1Letícia T. Silva2Giovanni F. Silva3Estela O. Lima4Aline F. Galvani5Guilherme L. Pereira6Adriana C. Ferrasi7Department of Internal Medicine, Medical School, Sao Paulo State University (UNESP), Botucatu 18618-687, SP, BrazilGrupo Biología y Control de Enfermedades Infecciosas (BCEI), Universidad de Antioquia (UdeA), Medellín 050010, ColombiaDepartment of Internal Medicine, Medical School, Sao Paulo State University (UNESP), Botucatu 18618-687, SP, BrazilDepartment of Internal Medicine, Medical School, Sao Paulo State University (UNESP), Botucatu 18618-687, SP, BrazilDepartment of Internal Medicine, Medical School, Sao Paulo State University (UNESP), Botucatu 18618-687, SP, BrazilDepartment of Internal Medicine, Medical School, Sao Paulo State University (UNESP), Botucatu 18618-687, SP, BrazilDepartment of Animal Breeding and Nutrition, School of Veterinary e Animal Science (FMVZ), São Paulo State University (Unesp), Botucatu 18618-681, SP, BrazilDepartment of Internal Medicine, Medical School, Sao Paulo State University (UNESP), Botucatu 18618-687, SP, Brazil<b>Background/Objectives:</b> LncRNAs have emerged as promising biomarkers due to their role in gene regulation of carcinogenesis and presence in biological fluids. Liquid biopsies offer a less invasive alternative to tissue biopsies, improving early cancer diagnosis and surveillance. Hepatocellular carcinoma (HCC) is among the most lethal and prevalent cancers. Late diagnoses contribute to poor prognosis, particularly in chronic hepatitis C (CHC) patients, which is a major risk factor for HCC. Tissue biopsies for HCC diagnosis pose risks, including tumor dissemination, highlighting the urgent need for noninvasive biomarkers. Several lncRNAs are deregulated in HCC and may be potential markers for assessing HCC risk in CHC. This study evaluated seven lncRNAs as plasma biomarkers for HCC risk in CHC. <b>Methods:</b> lncRNA expression was analyzed by RT-qPCR in three groups: CHC patients who developed HCC within a 5-year follow-up (HCCpos), CHC patients who did not develop HCC within a 5-year follow-up (HCCneg), and healthy blood donors (CG). <b>Results:</b> This study found that plasma lncRNAs HULC and RP11-731F5.2 are potential biomarkers for HCC risk, while RP11-731F5.2 and KCNQ1OT1 may serve as noninvasive biomarkers for liver damage due to HCV infection. <b>Conclusions:</b> These findings highlight the potential of lncRNAs in enhancing early diagnosis and monitoring of HCC in CHC patients.https://www.mdpi.com/1467-3045/47/5/348hepatocellular carcinomachronic hepatitis ClncRNAbiomarker |
| spellingShingle | Driéle B. dos Santos Geysson J. Fernandez Letícia T. Silva Giovanni F. Silva Estela O. Lima Aline F. Galvani Guilherme L. Pereira Adriana C. Ferrasi lncRNAs as Biomarkers of Hepatocellular Carcinoma Risk and Liver Damage in Advanced Chronic Hepatitis C Current Issues in Molecular Biology hepatocellular carcinoma chronic hepatitis C lncRNA biomarker |
| title | lncRNAs as Biomarkers of Hepatocellular Carcinoma Risk and Liver Damage in Advanced Chronic Hepatitis C |
| title_full | lncRNAs as Biomarkers of Hepatocellular Carcinoma Risk and Liver Damage in Advanced Chronic Hepatitis C |
| title_fullStr | lncRNAs as Biomarkers of Hepatocellular Carcinoma Risk and Liver Damage in Advanced Chronic Hepatitis C |
| title_full_unstemmed | lncRNAs as Biomarkers of Hepatocellular Carcinoma Risk and Liver Damage in Advanced Chronic Hepatitis C |
| title_short | lncRNAs as Biomarkers of Hepatocellular Carcinoma Risk and Liver Damage in Advanced Chronic Hepatitis C |
| title_sort | lncrnas as biomarkers of hepatocellular carcinoma risk and liver damage in advanced chronic hepatitis c |
| topic | hepatocellular carcinoma chronic hepatitis C lncRNA biomarker |
| url | https://www.mdpi.com/1467-3045/47/5/348 |
| work_keys_str_mv | AT drielebdossantos lncrnasasbiomarkersofhepatocellularcarcinomariskandliverdamageinadvancedchronichepatitisc AT geyssonjfernandez lncrnasasbiomarkersofhepatocellularcarcinomariskandliverdamageinadvancedchronichepatitisc AT leticiatsilva lncrnasasbiomarkersofhepatocellularcarcinomariskandliverdamageinadvancedchronichepatitisc AT giovannifsilva lncrnasasbiomarkersofhepatocellularcarcinomariskandliverdamageinadvancedchronichepatitisc AT estelaolima lncrnasasbiomarkersofhepatocellularcarcinomariskandliverdamageinadvancedchronichepatitisc AT alinefgalvani lncrnasasbiomarkersofhepatocellularcarcinomariskandliverdamageinadvancedchronichepatitisc AT guilhermelpereira lncrnasasbiomarkersofhepatocellularcarcinomariskandliverdamageinadvancedchronichepatitisc AT adrianacferrasi lncrnasasbiomarkersofhepatocellularcarcinomariskandliverdamageinadvancedchronichepatitisc |